Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Direct Intracranial Venous Stenting in Early IIH
NCT06919744Recruiting
- Sponsor
- CHU Montpellier
- Start
- Sep 2025
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by CHU Montpellier. Primary endpoint: Rate of patients with resolved papilledema and normalization of intra-cranial pressure at 3 months. Started Sep 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06919744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06919744.